Artifact
OxyContin
Extended-release oxycodone painkiller made by Purdue Pharma; approved by the FDA in 1995.
Connections 3
produced by
- Purdue Pharma Primary record 1
involved in
- FDA approval of OxyContin (1995) Scholarship & press 2
- OxyContin launch (1996) the drug launched Primary record 3
Proof 3 sources
-
Violations Prove Costly to Maker of OxyContin, U.S. Food and Drug Administration, 21 May 2007.
Primary record
Violations Prove Costly to Maker of OxyContin
-
The Family That Built an Empire of Pain, The New Yorker, 23 Oct 2017.
Scholarship & press
Purdue had conducted no clinical studies on how addictive or prone to abuse the drug might be.
absorption mechanism “is believed to reduce the abuse liability.”
But the F.D.A., in an unusual step, approved a package insert for OxyContin
-
The Purdue Frederick Company, Inc. and Top Executives Plead Guilty to Misbranding OxyContin; Will Pay Over $600 Million, U.S. Attorney’s Office, Western District of Virginia, 10 May 2007.
Primary record
Archived copy
beginning in January 1996 and continuing through June 30, 2001, Purdue’s market research found that “[t]he biggest negative of [OxyContin] was the abuse potential.”
Page history 1 change
- Add 55 stories, each checked against its sources96e92fe6
Something wrong or missing? Tell us, with a source, or edit this page.